We are live on ! Find out more
T

TOBAM Portfolio holdings

AUM $384M
1-Year Est. Return 10.32%
This Fund
S&P 500
This Quarter Est. Return
-0.63%
1 Year Est. Return
+10.32%
3 Year Est. Return
+36.67%
5 Year Est. Return
+41.37%
10 Year Est. Return
+233.72%
AUM
$1.52B
AUM Growth
+$6.76M
Cap. Flow
+$42.3M
Cap. Flow %
2.79%
Top 10 Hldgs %
27.44%
Holding
435
New
29
Increased
184
Reduced
112
Closed
75

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$21.1M
2
FSLR icon
First Solar
FSLR
+$15.7M
3
UTHR icon
United Therapeutics
UTHR
+$14.9M
4
HUM icon
Humana
HUM
+$14.6M
5
JNJ icon
Johnson & Johnson
JNJ
+$13.4M

Top Sells

Rank Stock Value
1
KMB icon
Kimberly-Clark
KMB
+$17M
2
ED icon
Consolidated Edison
ED
+$12.7M
3
EOG icon
EOG Resources
EOG
+$10.4M
4
ES icon
Eversource Energy
ES
+$9.97M
5
DGX icon
Quest Diagnostics
DGX
+$9.72M

Sector Composition

Rank Sector Weight
1 Healthcare 33.75%
2 Consumer Staples 26.59%
3 Technology 8.26%
4 Communication Services 7.04%
5 Financials 5.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MTB icon
251
M&T Bank
MTB
$36.1B
$165K 0.01%
1,382
+530
+62% +$76.9K
ROK icon
252
Rockwell Automation
ROK
$51.4B
$164K 0.01%
558
-118
-17% -$33.6K
MA icon
253
Mastercard
MA
$480B
$163K 0.01%
449
+377
+524% +$137K
ALL icon
254
Allstate
ALL
$64.3B
$162K 0.01%
1,462
– –
LUMN icon
255
Lumen
LUMN
$6.47B
$161K 0.01%
60,617
-39,568
-39% -$160K
BALL icon
256
Ball Corp
BALL
$16.7B
$160K 0.01%
2,909
+1,263
+77% +$70.2K
RVTY icon
257
Revvity
RVTY
$12.3B
$160K 0.01%
1,203
+521
+76% +$68.6K
XYL icon
258
Xylem
XYL
$29.2B
$159K 0.01%
1,520
+907
+148% +$94.7K
GPC icon
259
Genuine Parts
GPC
$17.2B
$157K 0.01%
937
+200
+27% +$33.7K
GPN icon
260
Global Payments
GPN
$21.3B
$156K 0.01%
1,482
+868
+141% +$94.1K
SUI icon
261
Sun Communities
SUI
$15B
$156K 0.01%
1,107
+485
+78% +$70.9K
NDAQ icon
262
Nasdaq
NDAQ
$51.8B
$153K 0.01%
2,802
+616
+28% +$35.6K
AVY icon
263
Avery Dennison
AVY
$12.3B
$150K 0.01%
841
+192
+30% +$34.9K
CCJ icon
264
Cameco
CCJ
$37.3B
$150K 0.01%
5,753
– –
DDOG icon
265
Datadog
DDOG
$92.1B
$148K 0.01%
2,032
+471
+30% +$34.6K
TTD icon
266
Trade Desk
TTD
$8.74B
$145K 0.01%
+2,383
New +$127K
ARE icon
267
Alexandria Real Estate Equities
ARE
$8.75B
$143K 0.01%
1,141
+716
+168% +$105K
ISRG icon
268
Intuitive Surgical
ISRG
$122B
$142K 0.01%
+554
New +$136K
ROL icon
269
Rollins
ROL
$21.7B
$142K 0.01%
3,775
+2,867
+316% +$103K
ADBE icon
270
Adobe
ADBE
$94.3B
$140K 0.01%
+364
New +$129K
ALGN icon
271
Align Technology
ALGN
$12.7B
$136K 0.01%
+408
New +$120K
PAYX icon
272
Paychex
PAYX
$40.7B
$132K 0.01%
+1,155
New +$131K
MAA icon
273
Mid-America Apartment Communities
MAA
$15.5B
$130K 0.01%
858
+220
+34% +$34.9K
VRSN icon
274
VeriSign
VRSN
$25.3B
$129K 0.01%
612
+446
+269% +$92K
EXPD icon
275
Expeditors International
EXPD
$23.9B
$128K 0.01%
1,166
+304
+35% +$33K
9 10
11
12 13

Similar funds

PCM
Pinnbrook Capital Management New York $384M AUM 147.48% 1-Year Est. Return
DFA
Delta Financial Advisors New Orleans, Louisiana $384M AUM 26.86% 1-Year Est. Return
BAMG
Brand Asset Management Group Chesterfield, Missouri $385M AUM 22.41% 1-Year Est. Return
DR
Davis Rea Toronto, Ontario, Canada $384M AUM 11.74% 1-Year Est. Return
GCP
Garda Capital Partners Wayzata, Minnesota $385M AUM 7.25% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return
GA
GSG Advisors Mount Laurel, New Jersey $385M AUM 19.83% 1-Year Est. Return
VI
VectorGlobal IAG Miami, Florida $385M AUM

TOBAM's Q1 2023 Portfolio in Review

As of Q1 2023, TOBAM held 435 positions worth $1.52B, up 0.45% from $1.51B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

TOBAM's Q1 2023 filing shows 29 new, 184 increased, 112 reduced and 75 closed positions. Its largest new stake was Bausch Health: 308,486 shares worth $2.49M. The largest sale was Kimberly-Clark, an estimated $17M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 34% a quarter earlier, followed by Consumer Staples and Technology.

  • TOBAM's largest Q1 2023 buy was Bausch Health: 308,486 shares worth $2.49M.
  • TOBAM added most to Bristol-Myers Squibb in Q1 2023, an estimated $21.1M increase.
  • TOBAM's biggest Q1 2023 reduction was Kimberly-Clark, cutting an estimated $17M.
  • TOBAM fully exited Stantec in Q1 2023, selling an estimated $1.26M.
  • TOBAM's ten largest holdings make up 27% of its $1.52B portfolio in Q1 2023.
  • TOBAM opened 29 new positions and closed 75 in Q1 2023.
  • TOBAM's portfolio value rose 0.45% quarter-over-quarter to $1.52B.

Based on TOBAM's 13F filing for Q1 2023, filed 3 May 2023.